Clinical Trials Logo
  1. Home
  2. THC
  3. NCT05641766

Multimodal Magnetoencephalography and Electroencephalography Exploration of the Acute Effects of THC Exposure on Neural Noise and Information Transmission Within Working Memory Networks — THC-MEG  

THC Clinical Trial

Official title:
Multimodal Magnetoencephalography and Electroencephalography Exploration of the Acute Effects of THC Exposure on Neural Noise and Information Transmission Within Working Memory Networks

Clinical Trial Summary

The purpose of this study is to use non-invasive brain imaging methods (MEG and EEG) to characterize the effects of THC on brain activity during learning.

Clinical Trial Description

The goal of this study is to use multimodal MEG/EEG to gain novel insight into the acute effects of THC on neural noise and its interaction with the fast information processing dynamics of the brain's cognition-related functional neural networks. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05641766
Study type Interventional
Source Yale University
Contact Jose Cortes-Briones, PhD
Phone 203-903-5711
Email jose.briones@yale.edu
Status Not yet recruiting
Phase Phase 2
Start date August 1, 2024
Completion date December 1, 2025
View Details
See also
  Status Clinical Trial Phase
Completed NCT04976738 - A Study of Cybis™ 10:25 THC:CBD Oil in Adults With Chronic Back/Neck Pain Phase 1/Phase 2
Not yet recruiting NCT06378957 - Behavioral Pharmacology of Orally Administered THC and D-limonene Phase 1
Active, not recruiting NCT03560934 - Tetrahydrocannabinol (THC) and Sleep Early Phase 1
Not yet recruiting NCT05999383 - Understanding the Clinical Pharmacology of Marijuana-Tobacco Co-administration Phase 2
Recruiting NCT04429568 - THC Crossover Study N/A
Recruiting NCT04130633 - Behavioral Pharmacology of THC and Alpha-pinene Phase 1
Completed NCT05121506 - A Study to Investigate the Bioavailability and Skin Absorption of CBD and THC From GT4 Technology in Healthy Adults Phase 1
Completed NCT04360044 - Efficacy of Inhaled Cannabis for Acute Migraine Treatment Phase 2
Withdrawn NCT04340700 - Characterization of the Pharmacodynamic Response to Vaped THC Phase 3
Not yet recruiting NCT06099379 - Modulation of THC Effects by CBD: a Dose-ranging Study Phase 1/Phase 2
Completed NCT04851392 - Do Adolescents and Adults Differ in Their Acute Response to Cannabis? N/A
Completed NCT04294966 - Age-Related Effects of THC Early Phase 1
Recruiting NCT05116527 - THC Memory & Reward Learning Pilot Phase 1/Phase 2
Recruiting NCT05514899 - Effects of Cannabidiol and Tetrahydrocannabinol on Microbiome and Neuroinflammation in HIV Phase 2
Not yet recruiting NCT03098940 - A Bioavailability Study on Dronabinol Phase 1
Active, not recruiting NCT02102113 - Probing the Cannabinoid System in Individuals With a Family History of Psychosis Early Phase 1
Not yet recruiting NCT06077292 - Cannabis THC Potency, Metabolism, and Cognitive Impairment in Young Adults N/A
Suspended NCT05427630 - Dose-Ranging Trial of Inhaled Cannabis for Acute Migraine Treatment Phase 2